Previous close | 2,185.29 |
Open | 2,195.22 |
Bid | 2,125.00 x 49400 |
Ask | 2,250.00 x 13500 |
Day's range | 2,195.22 - 2,195.22 |
52-week range | 1,725.90 - 2,252.70 |
Volume | |
Avg. volume | 1,648 |
Market cap | 5.56T |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | 145.57 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 51.09 (2.34%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
RAHWAY, N.J., May 15, 2024--Merck to Present New Data at 2024 ASCO Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
RAHWAY, N.J., May 13, 2024--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma
RAHWAY, N.J., May 09, 2024--Merck Provides Update on Phase 3 KEYNOTE-B21 Trial